TRX Biosciences

TRX Biosciences is a biotechnology company developing a targeted oral drug delivery platform, enabling therapies to reach specific organs, cells and tissues for cancer, central nervous system, respiratory and immune system diseases.

The company's technology is licensed to partner companies for use in their own drug development programmes, including a neuroscience partnership whose lead candidate has completed a Phase I clinical study, alongside development of TRX's own wholly-owned product pipeline.